← LL-37 overview

LL-37 Dosage & Reconstitution Guide

⚠ Systemic use of this antimicrobial peptide is genuinely experimental — human injection data is thin and it is pro-inflammatory in several tissue contexts.

Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.

Typical dose
100-500 mcg
Route
Subcutaneous injection
Frequency
once daily
After mixing
2.50 mg/mL (2500 mcg/mL)

Reconstitution

LL-37 ships as a freeze-dried (lyophilized) powder that has to be mixed with bacteriostatic water before use. Draw 2 mL of bacteriostatic water into a syringe and add it to a 5 mg vial, letting the stream run down the inside wall of the glass rather than blasting the powder directly. Swirl gently — never shake — until the solution is clear, then keep it refrigerated.

Worked example. 2 mL into a 5 mg vial gives a concentration of 2.50 mg/mL (2500 mcg/mL). A 250 mcg dose then works out to 0.1 mL = 10 units on a U-100 insulin syringe. Scale the water volume up or down to make your target dose land on an easy-to-read mark (1 unit = 0.01 mL).

  1. Wipe both vial stoppers (peptide and bacteriostatic water) with an alcohol swab and let them dry.
  2. Draw 2 mL of bacteriostatic water into a syringe.
  3. Inject it slowly against the inside wall of the peptide vial.
  4. Swirl gently until fully dissolved; do not shake.
  5. Label the vial with the contents, concentration, and date, and store it in the refrigerator.

Dosing schedule

Phase Dose Volume Insulin units (U-100) Notes
Weeks 1–2 100 mcg 0.04 mL 4 units once daily
Weeks 3+ 250 mcg 0.1 mL 10 units once daily, upper community range

Timing & cycling

Any consistent time; rotate sites diligently — site reactions are the most-reported issue.

Cycle length. Short courses only: 4–6 weeks, then stop and reassess.

Storage & handling

Keep the lyophilized (unmixed) vial refrigerated at 2–8 °C (36–46 °F) in a dry, dark place — it tolerates short periods at room temperature during shipping. Once reconstituted, store it at 2–8 °C, never frozen, and use it within about 2–4 weeks (sooner if the solution turns cloudy or discolored). Swab the stopper before every draw and use a fresh needle each time.

Supplies you'll need

  • LL-37 vials — about 3 for an 8-week run at the upper dose
  • Bacteriostatic water — 2 mL per vial (a 10–30 mL multi-dose bottle covers several vials)
  • U-100 insulin syringes (0.3–0.5 mL / 30–50 unit barrels are easiest to read) — roughly 56 for 8 weeks, plus spares
  • Alcohol swabs — one per injection and one per vial draw
  • Sharps container for safe needle disposal

Key points

  • Community dosing runs 100–500 mcg/day; the top of that range has the least precedent.
  • This is a host-defense peptide with double-edged biology (helpful against biofilms, implicated in autoimmune skin conditions) — the do-less option is rational.

What to monitor

Any spreading redness, joint pain, or systemic symptoms = stop.

Legal & prescription status

No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.

References

  1. doi.org
  2. doi.org
  3. doi.org
  4. doi.org
  5. doi.org
  6. doi.org

This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.